4Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive bloodpressure lowering and low-dose asipilin in patients with hyperte-naion principal results of the Hypertension Optimal Treatment(HOT)ran-domized trial[J].Lancet,1998,351:2075-2195
5Filling B,Sohiele R,Cin AK,et al.Characterization and clinical course oId tatients not receiving asiplin for acute myocardial infarction:Results form the MITRA and MIR srudies[J].Am Heart J,2001,141:200-205
3Antithrombotic Trials, Collaboration. Prevention of death, myocardial infarction end stroke by antiplatelet therapy in high risk patients. BM J, 2002; 324;71 ～ 86.
4Bertrand MF, Simoons ML, fox KA, et al. Management of acute Coronary syndromes: acute coronary synchromesh without persistent ST segment elevation recommendations of the Task Force of the European Society of Cardiology.Eur Heart J, 2000;21: 1406～1032.
5Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non - ST - segment elevation myocardial infarction. A report of the American College of Cardiology American Heart Association Task force on practice Guidelines (Committee on Management of Patients with Unstable Angina ) J Am Coll Cardiol, 2000;36:970 ～ 1062.
6TDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus Early treatment diabetic retinopathy study report 14. JAMA,1992;268: 1992～1300.
7Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low - dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial.Lancet, 1998;351: 2075～2195.
8Filling B, Schiele R, Gitt AK, et al. Characterization and clinical course old patients not receiving aspirin for acute myocardial infarction: Results form the MITRA and MIR studies. Am Heart J, 2001; 141: 200 ～ 205.
9Sleeper RB, Rofas- Fernandez C. Underu tilization of aspirin for secondary prophylaxis of cardiovascular disease in long - term - care facility. Am J Health - syst - Pharm, 2002;59: 1294～1295.
10Mach F. Toward new therapeutic strategies against neointimal formation in restenosis. Atheroscler Thromb Vasc Biol, 2000; 20:1699 ～ 1700.
